The EL ICD is powered by ENDURALIFE™ Battery Technology which is backed by four independent studies2-5 and over six years of real-world data6 that consistently demonstrated industry-leading longevity performance.

Key Resources

Explore

Product Details

Models D140, D141, D142, and D143

Powered by ENDURALIFE™ Battery Technology, which is backed by four independent studies2-5 and over six years of real-world data6 that consistently demonstrated industry-leading longevity performance.

The world’s thinnest ICD designed to enhance patient comfort.7

Includes the new EasyView™ header with color coded lead ports, designed to improve implant efficiency.

A clear header to easily verify full lead insertion

First-in-industry color-coded port labels to reduce the potential for misidentification of header ports

Offers an uncompromised set of features.

Features include:

– An advanced system solution for patient comorbidities and HF monitoring.

– EL defibrillators are compatible with LATITUDE™ NXT, Boston Scientific’s next generation remote patient management system. LATITUDE NXT features a simplified user-experience, streamlined interface and a comprehensive suite of diagnostics and alerts to help physicians make more informed decisions. Interrogations are all initiated by the Communicator. Daily checks for alerts are included in the published longevity estimates. With other manufacturers, longevity projections do not account for daily alert communications.8

– HF Perspectiv™ feature provides the only system with both a weight alert and an in-can diagnostic measuring respiratory rate, RRT (Respiratory Rate Trend).

– AcuShock™ Advanced is designed to help you better understand patients’ arrhythmias and reduce inappropriate therapy. When programmed with MADIT-RIT ARM B settings, Boston Scientific devices have shown a reduced risk of inappropriate therapy by 76-79% (P<0.001; HR=0.24;0.21 respectively) and the risk of death was decreased by 44-55% (P=0.06; HR=0.56; P=0.01; HR 0.45 respectively) when compared to conventional programming.9

– Safety Core™ technology is intended to provide lifesaving shock therapy and basic pacing functionality in the event of an unrecoverable fault.

– ENDOTAK RELIANCE™ is the industry’s most reliable lead with a survival probability of 98.5% at ten years.10,11 This family of leads maintains the same core design elements that have made Boston Scientific the leader in ICD lead reliability for the past 20 years.

– Unlike other manufacturers, Boston Scientific’s 3-channel EGM Onset is turned On permanently and does not impact battery longevity projections.8

d Projected longevity is calculated assuming 3 maximum energy charging cycles per year, including automatic capacitor re-forms and therapeutic shocks. For the final year of device service, an additional 5 charging cycles are assumed to account for additional automatic capacitor re-forms as the device approaches the Explant indicator. These calculations also assume 3-channel EGM Onset is set to On, and that the pulse generator spends 6 months in Storage mode during shipping and storage.

Additional Longevity Information

For longevity calculations based on different settings please contact Boston Scientific technical services or your local
representative.

Boston Scientific devices have limited warranties at 10 years (VR) and 8 years (DR) in available geographies. See BostonScientific.com/warranty for complete warranty terms and conditions.

6. Not intended to replace longevity estimates found in labeling. Analysis of LATITUDE™ Patient Management system data (data on file):
─ From oldest 1000 VR, DR and 999 CRT-Ds as of October 2013. This distributions may be different than later groups. Data on file.
─ Individual symptoms, situations, circumstances and results vary. This information is not intended to be used for medical diagnosis or treatment or as a substitute for medical advice.
─ Device programming was determined by physicians. Accordingly, the aggregate average represents a mean value that is based upon real-world programming. The data reflect projected longevities based upon parameter settings, rather than observed performance.
─ This information is a defined data set and could change in the future.
─ The low variability may be the result of the devices still being quite young. As the devices continue to age, patient differences in pacing and other factors may cause greater variability in the Approximate Time to Explant.
─ The LATITUDE data are assumed to be representative of the general patient population.
─ The distribution is non-normal; therefore the standard deviation must be interpreted with care. It may not necessarily be true that ~ 95% of the data lie within standard deviations of the mean, ~99.7% within three, etc.